The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 38, No. 1, pp. 176-177. DOI 10.1345/aph.1C086c
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Retraction: acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis

Published Online, November 17, 2003. www.theannals.com, DOI 10.1345/aph.1C086c
We have become aware that the case described in a recent Letter to the Editor by Mogenet et al.1 has been reported previously in the medical literature.2 Therefore, we are retracting the original letter by Mogenet et al.

Whenever the journal accepts an article that claims to be the first reported case in the literature, the authors are asked to verify that claim immediately prior to publication. In this instance, the galley verification was returned several months after publication of the initial report in Neurology.2 However the authors failed to notice this earlier report, which was authored by other clinicians at their institution.

Duplicate reporting of an adverse event distorts estimates of its true incidence and has other negative consequences for the medical literature.3 Often this can be inadvertent. Upon learning of the duplication, Mogenet et al. informed us that they had initially notified their hospital's administration of their intent to publish the case in The Annals and that they were not made aware of the other report. This highlights the need to perform careful, comprehensive literature searches both when initially writing a paper and immediately prior to its publication. — EDS

References

  1. Mogenet I, Simiand-Erdociain E, Canonge J-M, Pris J. Acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis (letter). Ann Pharmacother 2003;37: 747-8. DOI 10.1345/aph.1C086[Free Full Text]
  2. Brassat D, Recher C, Waubant E, Le Page E, Rigal-Huguet F, Laurent G, et al. Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS. Neurology 2002;59:954-5.[Abstract/Free Full Text]
  3. Lloyd SJ, Whitney H. Publishing ethics: duplication indiscretion.Ann Pharmacother 2003;37:147. DOI 10.1345/aph.1C496[Free Full Text]




This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

homecopy help contact us subscription past issues search current issue